1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global mRNA Flu Vaccine Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for mRNA Flu Vaccine by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for mRNA Flu Vaccine by Country/Region, 2019, 2023 & 2030 2.2 mRNA Flu Vaccine Segment by Type 2.2.1 mRNA-1010 2.2.2 mRNA-1020 2.2.3 mRNA-1030 2.3 mRNA Flu Vaccine Sales by Type 2.3.1 Global mRNA Flu Vaccine Sales Market Share by Type (2019-2024) 2.3.2 Global mRNA Flu Vaccine Revenue and Market Share by Type (2019-2024) 2.3.3 Global mRNA Flu Vaccine Sale Price by Type (2019-2024) 2.4 mRNA Flu Vaccine Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Other 2.5 mRNA Flu Vaccine Sales by Application 2.5.1 Global mRNA Flu Vaccine Sale Market Share by Application (2019-2024) 2.5.2 Global mRNA Flu Vaccine Revenue and Market Share by Application (2019-2024) 2.5.3 Global mRNA Flu Vaccine Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global mRNA Flu Vaccine Breakdown Data by Company 3.1.1 Global mRNA Flu Vaccine Annual Sales by Company (2019-2024) 3.1.2 Global mRNA Flu Vaccine Sales Market Share by Company (2019-2024) 3.2 Global mRNA Flu Vaccine Annual Revenue by Company (2019-2024) 3.2.1 Global mRNA Flu Vaccine Revenue by Company (2019-2024) 3.2.2 Global mRNA Flu Vaccine Revenue Market Share by Company (2019-2024) 3.3 Global mRNA Flu Vaccine Sale Price by Company 3.4 Key Manufacturers mRNA Flu Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers mRNA Flu Vaccine Product Location Distribution 3.4.2 Players mRNA Flu Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for mRNA Flu Vaccine by Geographic Region 4.1 World Historic mRNA Flu Vaccine Market Size by Geographic Region (2019-2024) 4.1.1 Global mRNA Flu Vaccine Annual Sales by Geographic Region (2019-2024) 4.1.2 Global mRNA Flu Vaccine Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic mRNA Flu Vaccine Market Size by Country/Region (2019-2024) 4.2.1 Global mRNA Flu Vaccine Annual Sales by Country/Region (2019-2024) 4.2.2 Global mRNA Flu Vaccine Annual Revenue by Country/Region (2019-2024) 4.3 Americas mRNA Flu Vaccine Sales Growth 4.4 APAC mRNA Flu Vaccine Sales Growth 4.5 Europe mRNA Flu Vaccine Sales Growth 4.6 Middle East & Africa mRNA Flu Vaccine Sales Growth 5 Americas 5.1 Americas mRNA Flu Vaccine Sales by Country 5.1.1 Americas mRNA Flu Vaccine Sales by Country (2019-2024) 5.1.2 Americas mRNA Flu Vaccine Revenue by Country (2019-2024) 5.2 Americas mRNA Flu Vaccine Sales by Type (2019-2024) 5.3 Americas mRNA Flu Vaccine Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC mRNA Flu Vaccine Sales by Region 6.1.1 APAC mRNA Flu Vaccine Sales by Region (2019-2024) 6.1.2 APAC mRNA Flu Vaccine Revenue by Region (2019-2024) 6.2 APAC mRNA Flu Vaccine Sales by Type (2019-2024) 6.3 APAC mRNA Flu Vaccine Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe mRNA Flu Vaccine by Country 7.1.1 Europe mRNA Flu Vaccine Sales by Country (2019-2024) 7.1.2 Europe mRNA Flu Vaccine Revenue by Country (2019-2024) 7.2 Europe mRNA Flu Vaccine Sales by Type (2019-2024) 7.3 Europe mRNA Flu Vaccine Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa mRNA Flu Vaccine by Country 8.1.1 Middle East & Africa mRNA Flu Vaccine Sales by Country (2019-2024) 8.1.2 Middle East & Africa mRNA Flu Vaccine Revenue by Country (2019-2024) 8.2 Middle East & Africa mRNA Flu Vaccine Sales by Type (2019-2024) 8.3 Middle East & Africa mRNA Flu Vaccine Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of mRNA Flu Vaccine 10.3 Manufacturing Process Analysis of mRNA Flu Vaccine 10.4 Industry Chain Structure of mRNA Flu Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 mRNA Flu Vaccine Distributors 11.3 mRNA Flu Vaccine Customer 12 World Forecast Review for mRNA Flu Vaccine by Geographic Region 12.1 Global mRNA Flu Vaccine Market Size Forecast by Region 12.1.1 Global mRNA Flu Vaccine Forecast by Region (2025-2030) 12.1.2 Global mRNA Flu Vaccine Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global mRNA Flu Vaccine Forecast by Type (2025-2030) 12.7 Global mRNA Flu Vaccine Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Moderna 13.1.1 Moderna Company Information 13.1.2 Moderna mRNA Flu Vaccine Product Portfolios and Specifications 13.1.3 Moderna mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Moderna Main Business Overview 13.1.5 Moderna Latest Developments 13.2 BioNTech 13.2.1 BioNTech Company Information 13.2.2 BioNTech mRNA Flu Vaccine Product Portfolios and Specifications 13.2.3 BioNTech mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 BioNTech Main Business Overview 13.2.5 BioNTech Latest Developments 13.3 CureVac 13.3.1 CureVac Company Information 13.3.2 CureVac mRNA Flu Vaccine Product Portfolios and Specifications 13.3.3 CureVac mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 CureVac Main Business Overview 13.3.5 CureVac Latest Developments 13.4 Novavax 13.4.1 Novavax Company Information 13.4.2 Novavax mRNA Flu Vaccine Product Portfolios and Specifications 13.4.3 Novavax mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Novavax Main Business Overview 13.4.5 Novavax Latest Developments 13.5 Sanofi 13.5.1 Sanofi Company Information 13.5.2 Sanofi mRNA Flu Vaccine Product Portfolios and Specifications 13.5.3 Sanofi mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Sanofi Main Business Overview 13.5.5 Sanofi Latest Developments 13.6 Inovio Pharmaceuticals 13.6.1 Inovio Pharmaceuticals Company Information 13.6.2 Inovio Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications 13.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Inovio Pharmaceuticals Main Business Overview 13.6.5 Inovio Pharmaceuticals Latest Developments 13.7 Arcturus Therapeutics Holdings 13.7.1 Arcturus Therapeutics Holdings Company Information 13.7.2 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Portfolios and Specifications 13.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Arcturus Therapeutics Holdings Main Business Overview 13.7.5 Arcturus Therapeutics Holdings Latest Developments 13.8 eTheRNA immunotherapies 13.8.1 eTheRNA immunotherapies Company Information 13.8.2 eTheRNA immunotherapies mRNA Flu Vaccine Product Portfolios and Specifications 13.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 eTheRNA immunotherapies Main Business Overview 13.8.5 eTheRNA immunotherapies Latest Developments 13.9 Valneva 13.9.1 Valneva Company Information 13.9.2 Valneva mRNA Flu Vaccine Product Portfolios and Specifications 13.9.3 Valneva mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Valneva Main Business Overview 13.9.5 Valneva Latest Developments 13.10 Vaxart 13.10.1 Vaxart Company Information 13.10.2 Vaxart mRNA Flu Vaccine Product Portfolios and Specifications 13.10.3 Vaxart mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Vaxart Main Business Overview 13.10.5 Vaxart Latest Developments 13.11 Entos Pharmaceuticals 13.11.1 Entos Pharmaceuticals Company Information 13.11.2 Entos Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications 13.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Entos Pharmaceuticals Main Business Overview 13.11.5 Entos Pharmaceuticals Latest Developments 13.12 Abnova Corporation 13.12.1 Abnova Corporation Company Information 13.12.2 Abnova Corporation mRNA Flu Vaccine Product Portfolios and Specifications 13.12.3 Abnova Corporation mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Abnova Corporation Main Business Overview 13.12.5 Abnova Corporation Latest Developments 13.13 Anima Biotech 13.13.1 Anima Biotech Company Information 13.13.2 Anima Biotech mRNA Flu Vaccine Product Portfolios and Specifications 13.13.3 Anima Biotech mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 Anima Biotech Main Business Overview 13.13.5 Anima Biotech Latest Developments 13.14 Sarepta Therapeutics 13.14.1 Sarepta Therapeutics Company Information 13.14.2 Sarepta Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications 13.14.3 Sarepta Therapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Sarepta Therapeutics Main Business Overview 13.14.5 Sarepta Therapeutics Latest Developments 13.15 iBio 13.15.1 iBio Company Information 13.15.2 iBio mRNA Flu Vaccine Product Portfolios and Specifications 13.15.3 iBio mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 iBio Main Business Overview 13.15.5 iBio Latest Developments 13.16 Barinthus Biotherapeutics 13.16.1 Barinthus Biotherapeutics Company Information 13.16.2 Barinthus Biotherapeutics mRNA Flu Vaccine Product Portfolios and Specifications 13.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.16.4 Barinthus Biotherapeutics Main Business Overview 13.16.5 Barinthus Biotherapeutics Latest Developments 13.17 Alnylam Pharmaceuticals 13.17.1 Alnylam Pharmaceuticals Company Information 13.17.2 Alnylam Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications 13.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.17.4 Alnylam Pharmaceuticals Main Business Overview 13.17.5 Alnylam Pharmaceuticals Latest Developments 13.18 Beam Therapeutics 13.18.1 Beam Therapeutics Company Information 13.18.2 Beam Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications 13.18.3 Beam Therapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.18.4 Beam Therapeutics Main Business Overview 13.18.5 Beam Therapeutics Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. mRNA Flu Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. mRNA Flu Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of mRNA-1010 Table 4. Major Players of mRNA-1020 Table 5. Major Players of mRNA-1030 Table 6. Global mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units) Table 7. Global mRNA Flu Vaccine Sales Market Share by Type (2019-2024) Table 8. Global mRNA Flu Vaccine Revenue by Type (2019-2024) & ($ million) Table 9. Global mRNA Flu Vaccine Revenue Market Share by Type (2019-2024) Table 10. Global mRNA Flu Vaccine Sale Price by Type (2019-2024) & (US$/Unit) Table 11. Global mRNA Flu Vaccine Sale by Application (2019-2024) & (K Units) Table 12. Global mRNA Flu Vaccine Sale Market Share by Application (2019-2024) Table 13. Global mRNA Flu Vaccine Revenue by Application (2019-2024) & ($ million) Table 14. Global mRNA Flu Vaccine Revenue Market Share by Application (2019-2024) Table 15. Global mRNA Flu Vaccine Sale Price by Application (2019-2024) & (US$/Unit) Table 16. Global mRNA Flu Vaccine Sales by Company (2019-2024) & (K Units) Table 17. Global mRNA Flu Vaccine Sales Market Share by Company (2019-2024) Table 18. Global mRNA Flu Vaccine Revenue by Company (2019-2024) & ($ millions) Table 19. Global mRNA Flu Vaccine Revenue Market Share by Company (2019-2024) Table 20. Global mRNA Flu Vaccine Sale Price by Company (2019-2024) & (US$/Unit) Table 21. Key Manufacturers mRNA Flu Vaccine Producing Area Distribution and Sales Area Table 22. Players mRNA Flu Vaccine Products Offered Table 23. mRNA Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 24. New Products and Potential Entrants Table 25. Market M&A Activity & Strategy Table 26. Global mRNA Flu Vaccine Sales by Geographic Region (2019-2024) & (K Units) Table 27. Global mRNA Flu Vaccine Sales Market Share Geographic Region (2019-2024) Table 28. Global mRNA Flu Vaccine Revenue by Geographic Region (2019-2024) & ($ millions) Table 29. Global mRNA Flu Vaccine Revenue Market Share by Geographic Region (2019-2024) Table 30. Global mRNA Flu Vaccine Sales by Country/Region (2019-2024) & (K Units) Table 31. Global mRNA Flu Vaccine Sales Market Share by Country/Region (2019-2024) Table 32. Global mRNA Flu Vaccine Revenue by Country/Region (2019-2024) & ($ millions) Table 33. Global mRNA Flu Vaccine Revenue Market Share by Country/Region (2019-2024) Table 34. Americas mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units) Table 35. Americas mRNA Flu Vaccine Sales Market Share by Country (2019-2024) Table 36. Americas mRNA Flu Vaccine Revenue by Country (2019-2024) & ($ millions) Table 37. Americas mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units) Table 38. Americas mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units) Table 39. APAC mRNA Flu Vaccine Sales by Region (2019-2024) & (K Units) Table 40. APAC mRNA Flu Vaccine Sales Market Share by Region (2019-2024) Table 41. APAC mRNA Flu Vaccine Revenue by Region (2019-2024) & ($ millions) Table 42. APAC mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units) Table 43. APAC mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units) Table 44. Europe mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units) Table 45. Europe mRNA Flu Vaccine Revenue by Country (2019-2024) & ($ millions) Table 46. Europe mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units) Table 47. Europe mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units) Table 48. Middle East & Africa mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units) Table 49. Middle East & Africa mRNA Flu Vaccine Revenue Market Share by Country (2019-2024) Table 50. Middle East & Africa mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units) Table 51. Middle East & Africa mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units) Table 52. Key Market Drivers & Growth Opportunities of mRNA Flu Vaccine Table 53. Key Market Challenges & Risks of mRNA Flu Vaccine Table 54. Key Industry Trends of mRNA Flu Vaccine Table 55. mRNA Flu Vaccine Raw Material Table 56. Key Suppliers of Raw Materials Table 57. mRNA Flu Vaccine Distributors List Table 58. mRNA Flu Vaccine Customer List Table 59. Global mRNA Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units) Table 60. Global mRNA Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions) Table 61. Americas mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units) Table 62. Americas mRNA Flu Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions) Table 63. APAC mRNA Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units) Table 64. APAC mRNA Flu Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions) Table 65. Europe mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units) Table 66. Europe mRNA Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions) Table 67. Middle East & Africa mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units) Table 68. Middle East & Africa mRNA Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions) Table 69. Global mRNA Flu Vaccine Sales Forecast by Type (2025-2030) & (K Units) Table 70. Global mRNA Flu Vaccine Revenue Forecast by Type (2025-2030) & ($ millions) Table 71. Global mRNA Flu Vaccine Sales Forecast by Application (2025-2030) & (K Units) Table 72. Global mRNA Flu Vaccine Revenue Forecast by Application (2025-2030) & ($ millions) Table 73. Moderna Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 74. Moderna mRNA Flu Vaccine Product Portfolios and Specifications Table 75. Moderna mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 76. Moderna Main Business Table 77. Moderna Latest Developments Table 78. BioNTech Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 79. BioNTech mRNA Flu Vaccine Product Portfolios and Specifications Table 80. BioNTech mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 81. BioNTech Main Business Table 82. BioNTech Latest Developments Table 83. CureVac Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 84. CureVac mRNA Flu Vaccine Product Portfolios and Specifications Table 85. CureVac mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 86. CureVac Main Business Table 87. CureVac Latest Developments Table 88. Novavax Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 89. Novavax mRNA Flu Vaccine Product Portfolios and Specifications Table 90. Novavax mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 91. Novavax Main Business Table 92. Novavax Latest Developments Table 93. Sanofi Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 94. Sanofi mRNA Flu Vaccine Product Portfolios and Specifications Table 95. Sanofi mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 96. Sanofi Main Business Table 97. Sanofi Latest Developments Table 98. Inovio Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 99. Inovio Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications Table 100. Inovio Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 101. Inovio Pharmaceuticals Main Business Table 102. Inovio Pharmaceuticals Latest Developments Table 103. Arcturus Therapeutics Holdings Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 104. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Portfolios and Specifications Table 105. Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 106. Arcturus Therapeutics Holdings Main Business Table 107. Arcturus Therapeutics Holdings Latest Developments Table 108. eTheRNA immunotherapies Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 109. eTheRNA immunotherapies mRNA Flu Vaccine Product Portfolios and Specifications Table 110. eTheRNA immunotherapies mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 111. eTheRNA immunotherapies Main Business Table 112. eTheRNA immunotherapies Latest Developments Table 113. Valneva Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 114. Valneva mRNA Flu Vaccine Product Portfolios and Specifications Table 115. Valneva mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 116. Valneva Main Business Table 117. Valneva Latest Developments Table 118. Vaxart Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 119. Vaxart mRNA Flu Vaccine Product Portfolios and Specifications Table 120. Vaxart mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 121. Vaxart Main Business Table 122. Vaxart Latest Developments Table 123. Entos Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 124. Entos Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications Table 125. Entos Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 126. Entos Pharmaceuticals Main Business Table 127. Entos Pharmaceuticals Latest Developments Table 128. Abnova Corporation Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 129. Abnova Corporation mRNA Flu Vaccine Product Portfolios and Specifications Table 130. Abnova Corporation mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 131. Abnova Corporation Main Business Table 132. Abnova Corporation Latest Developments Table 133. Anima Biotech Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 134. Anima Biotech mRNA Flu Vaccine Product Portfolios and Specifications Table 135. Anima Biotech mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 136. Anima Biotech Main Business Table 137. Anima Biotech Latest Developments Table 138. Sarepta Therapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 139. Sarepta Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications Table 140. Sarepta Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 141. Sarepta Therapeutics Main Business Table 142. Sarepta Therapeutics Latest Developments Table 143. iBio Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 144. iBio mRNA Flu Vaccine Product Portfolios and Specifications Table 145. iBio mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 146. iBio Main Business Table 147. iBio Latest Developments Table 148. Barinthus Biotherapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 149. Barinthus Biotherapeutics mRNA Flu Vaccine Product Portfolios and Specifications Table 150. Barinthus Biotherapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 151. Barinthus Biotherapeutics Main Business Table 152. Barinthus Biotherapeutics Latest Developments Table 153. Alnylam Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 154. Alnylam Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications Table 155. Alnylam Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 156. Alnylam Pharmaceuticals Main Business Table 157. Alnylam Pharmaceuticals Latest Developments Table 158. Beam Therapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors Table 159. Beam Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications Table 160. Beam Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 161. Beam Therapeutics Main Business Table 162. Beam Therapeutics Latest Developments List of Figures Figure 1. Picture of mRNA Flu Vaccine Figure 2. mRNA Flu Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global mRNA Flu Vaccine Sales Growth Rate 2019-2030 (K Units) Figure 7. Global mRNA Flu Vaccine Revenue Growth Rate 2019-2030 ($ millions) Figure 8. mRNA Flu Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 9. mRNA Flu Vaccine Sales Market Share by Country/Region (2023) Figure 10. mRNA Flu Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 11. Product Picture of mRNA-1010 Figure 12. Product Picture of mRNA-1020 Figure 13. Product Picture of mRNA-1030 Figure 14. Global mRNA Flu Vaccine Sales Market Share by Type in 2023 Figure 15. Global mRNA Flu Vaccine Revenue Market Share by Type (2019-2024) Figure 16. mRNA Flu Vaccine Consumed in Hospital Figure 17. Global mRNA Flu Vaccine Market: Hospital (2019-2024) & (K Units) Figure 18. mRNA Flu Vaccine Consumed in Clinic Figure 19. Global mRNA Flu Vaccine Market: Clinic (2019-2024) & (K Units) Figure 20. mRNA Flu Vaccine Consumed in Other Figure 21. Global mRNA Flu Vaccine Market: Other (2019-2024) & (K Units) Figure 22. Global mRNA Flu Vaccine Sale Market Share by Application (2023) Figure 23. Global mRNA Flu Vaccine Revenue Market Share by Application in 2023 Figure 24. mRNA Flu Vaccine Sales by Company in 2023 (K Units) Figure 25. Global mRNA Flu Vaccine Sales Market Share by Company in 2023 Figure 26. mRNA Flu Vaccine Revenue by Company in 2023 ($ millions) Figure 27. Global mRNA Flu Vaccine Revenue Market Share by Company in 2023 Figure 28. Global mRNA Flu Vaccine Sales Market Share by Geographic Region (2019-2024) Figure 29. Global mRNA Flu Vaccine Revenue Market Share by Geographic Region in 2023 Figure 30. Americas mRNA Flu Vaccine Sales 2019-2024 (K Units) Figure 31. Americas mRNA Flu Vaccine Revenue 2019-2024 ($ millions) Figure 32. APAC mRNA Flu Vaccine Sales 2019-2024 (K Units) Figure 33. APAC mRNA Flu Vaccine Revenue 2019-2024 ($ millions) Figure 34. Europe mRNA Flu Vaccine Sales 2019-2024 (K Units) Figure 35. Europe mRNA Flu Vaccine Revenue 2019-2024 ($ millions) Figure 36. Middle East & Africa mRNA Flu Vaccine Sales 2019-2024 (K Units) Figure 37. Middle East & Africa mRNA Flu Vaccine Revenue 2019-2024 ($ millions) Figure 38. Americas mRNA Flu Vaccine Sales Market Share by Country in 2023 Figure 39. Americas mRNA Flu Vaccine Revenue Market Share by Country (2019-2024) Figure 40. Americas mRNA Flu Vaccine Sales Market Share by Type (2019-2024) Figure 41. Americas mRNA Flu Vaccine Sales Market Share by Application (2019-2024) Figure 42. United States mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 43. Canada mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 44. Mexico mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 45. Brazil mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 46. APAC mRNA Flu Vaccine Sales Market Share by Region in 2023 Figure 47. APAC mRNA Flu Vaccine Revenue Market Share by Region (2019-2024) Figure 48. APAC mRNA Flu Vaccine Sales Market Share by Type (2019-2024) Figure 49. APAC mRNA Flu Vaccine Sales Market Share by Application (2019-2024) Figure 50. China mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 51. Japan mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 52. South Korea mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 53. Southeast Asia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 54. India mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 55. Australia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 56. China Taiwan mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 57. Europe mRNA Flu Vaccine Sales Market Share by Country in 2023 Figure 58. Europe mRNA Flu Vaccine Revenue Market Share by Country (2019-2024) Figure 59. Europe mRNA Flu Vaccine Sales Market Share by Type (2019-2024) Figure 60. Europe mRNA Flu Vaccine Sales Market Share by Application (2019-2024) Figure 61. Germany mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 62. France mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 63. UK mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 64. Italy mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 65. Russia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 66. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Country (2019-2024) Figure 67. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Type (2019-2024) Figure 68. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Application (2019-2024) Figure 69. Egypt mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 70. South Africa mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 71. Israel mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 72. Turkey mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 73. GCC Countries mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions) Figure 74. Manufacturing Cost Structure Analysis of mRNA Flu Vaccine in 2023 Figure 75. Manufacturing Process Analysis of mRNA Flu Vaccine Figure 76. Industry Chain Structure of mRNA Flu Vaccine Figure 77. Channels of Distribution Figure 78. Global mRNA Flu Vaccine Sales Market Forecast by Region (2025-2030) Figure 79. Global mRNA Flu Vaccine Revenue Market Share Forecast by Region (2025-2030) Figure 80. Global mRNA Flu Vaccine Sales Market Share Forecast by Type (2025-2030) Figure 81. Global mRNA Flu Vaccine Revenue Market Share Forecast by Type (2025-2030) Figure 82. Global mRNA Flu Vaccine Sales Market Share Forecast by Application (2025-2030) Figure 83. Global mRNA Flu Vaccine Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Moderna"|||"BioNTech"|||"CureVac"|||"Novavax"|||"Sanofi"|||"Inovio Pharmaceuticals"|||"Arcturus Therapeutics Holdings"|||"eTheRNA immunotherapies"|||"Valneva"|||"Vaxart"|||"Entos Pharmaceuticals"|||"Abnova Corporation"|||"Anima Biotech"|||"Sarepta Therapeutics"|||"iBio"|||"Barinthus Biotherapeutics"|||"Alnylam Pharmaceuticals"|||"Beam Therapeutics"